A functional simulation requires many manual inputs, including data smoothing, vendor collaboration, and even direct communication with tenured employees who know the job best.
- Good Distribution Practice Is Evolving — Here's How
- Atsena Therapeutics Advances Gene Therapy For XLRS
- 3 Strategies For A Successful Journey Toward Cell And Gene Therapy Commercialization
- A Case For Paying Allogeneic Cell Therapy Product Donors
- Protecting Intellectual Property In The Genomics Revolution
- April 2025 — CDMO Opportunities And Threats Report
- A Road Map For PAT Monitoring And Control
- Is Early Automation The Key To Scalable Cell Therapy Manufacturing?
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Optimizing DPI Production: Filling Technologies For Precision And Performance
Developing effective dry powder inhalers requires expertise across multiple disciplines, from particle engineering and device technology to manufacturing science and regulatory knowledge.
-
Harvest Of HEK Cells In Extracellular Expression Systems
Evaluate the performance of a single-use centrifuge biopharmaceutical organizations can utilize in the clarification of Expi293F cells through its measuring of supernatant turbidity and viable cell recovery (VCR).
-
Evaluating The Expression Patterns Of Multiple Inhibitory Receptors
Discover how an innovative approach to interpreting T-cell exhaustion and inhibitory receptor expression is paving the way for innovative therapeutic approaches aimed at rejuvenating T-cell function.
-
How To Successfully Isolate Your T Cells
Explore the results of a study focusing on the early stages of the CAR T cell workflow, specifically the initial washing of leukapheresis followed by the isolation of T cells.
-
Meeting Annex 1: A Proactive Approach To Regulatory Compliance
It was imperative for a large European CMO that produces multiple biologic drugs to select the right product quality and value for each customer to comply with the August 2023 revision to the EU GMP Annex 1.
-
Multiplex Imaging
Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.
-
Addressing Site Selection Challenges In DMD Gene Therapy Studies
Effective site selection is critical for the success of DMD gene therapy trials. This study details innovative methodologies employed to streamline and improve site identification.
-
Epigenetics Application Guide
To fully understand biology and disease mechanisms, it is crucial to explore the role of epigenetic factors. Explore how epigenetic regulation works and methods to study these essential components.
-
Single-Use Assembly Capabilities To Keep Pace With Biopharma Dynamics
Discover how a vendor-independent partner assists global life science companies and CDMOs with innovative single-use technologies to mitigate risks and ensure uninterrupted manufacturing.
-
Trends In Next-Generation Delivery Technologies
Learn how lipid nanoparticles are enabling a new generation of engineered cell therapies with a push toward more complex cell engineering and gene editing for allogeneic therapies.
NEWSLETTER ARCHIVE
- 05.20.25 -- STREAM Edition: Optimization-By-Design — A Critical Factor In Viral Vector Scale Up
- 05.20.25 -- Is Early Automation The Key To Scalable Cell Therapy Manufacturing?
- 05.19.25 -- Find Cell And Gene Therapy Supply Chain Support
- 05.19.25 -- Direct Access To Today's Leading CDMOs
- 05.19.25 -- April 2025 — CDMO Opportunities And Threats Report

- Ferring Builds A Global Gene Therapy Manufacturing Network Around ADSTILADRIN
- Atsena Therapeutics Advances Gene Therapy For XLRS
- Navigating CGT Biotech's Financial Headwinds And The Path Forward
- How Cynata Therapeutics is Unlocking the Power of iPSCs to Transform Regenerative Medicine
- Emerging Technologies For Cell Therapy Manufacturing
CELL AND GENE CONTENT COLLECTIONS

While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections